HIMS insiders

18 insiders have filed at HIMS since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Dudum AndrewChief Executive Officer9.53M4.173%146 sells $203.8M
Baird MelissaChief Operating Officer805.1k0.353%92 sells $23.4M
Chi MichaelChief Operating Officer407.3k0.178%52 sells $37.6M
Okupe OluyemiChief Financial Officer326.6k0.143%85 sells $44.8M
Boughton SoleilChief Legal Officer308.8k0.135%58 sells $18.7M
Carroll Patrick HarrisonChief Medical Officer182.4k0.08%8 sells $5.7M
Wells David BDirector176.0k0.077%2 sells $4.6M
Payne Christopher DDirector130.0k0.057%1 buys $2.0M
Bhattacharyya AmbarDirector91.0k0.04%
Perez Garcia Andrea GDirector80.2k0.035%1 sells $98k
Bard AlexDirector74.8k0.033%
Cosgrove Delos M.Director64.3k0.028%
Pendarvis ChristianeDirector51.8k0.023%3 sells $655k
Autor Deborah M.Chief Policy Officer27.8k0.012%1 sells $259k
Manuel AnjaDirector25.0k0.011%2 buys $132k
O'Keefe Lynne ChouDirector19.7k<0.01%4 sells $634k
Schultz KareDirector15.7k<0.01%
Becklund IrenePao8.8k<0.01%29 sells $3.9M

Full register at boothcheck.com/insiders/HIMS. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

HIMS institutional holders · HIMS research report